Stockscreener 앱 받기
873.68
0.06%
0.56
시간 외 거래:
872.29
-1.39
-0.16%
Lilly Eli Co 주식(LLY)의 최신 뉴스
3 Magnificent Growth Stocks to Buy Right Now - The Motley Fool
Major Stock Movement: Lilly Endowment Inc Sells Shares of Eli Lilly & Co - TipRanks
Eli Lilly Has Exclusivity Over Weight Loss Drug, FDA Says - Law360
Lilly Endowment sells $12.9 million in Eli Lilly stock - Investing.com
Is Eli Lilly and Company (LLY) the Best Non-Tech Stock to Buy Now for Long Term? - Insider Monkey
Eli Lilly bets big on weight-loss pill with $550 million inventory stockpile - Reuters.com
Eli Lilly (LLY): Buy, Sell, or Hold Post Q4 Earnings? - Yahoo Finance
Major Shareholder Makes a Big Move with Eli Lilly & Co Stock! - TipRanks
Lilly Endowment Inc sells $8.77 million in Eli Lilly shares By Investing.com - Investing.com UK
ELI LILLY AND COMPANY (LLY) - MSN
Eli Lilly's Options Frenzy: What You Need to Know - Benzinga
The Alzheimer's Drug Discovery Foundation Announces Daniel M. Skovronsky, MD, PhD, of Eli Lilly & Company, as Recipient of Prestigious 2025 Melvin R. Goodes Prize - citybiz
Eli Lilly and Company (LLY): Among the Best Long-Term Stocks to Buy According to Ken Fisher - Insider Monkey
Eli Lilly bets big on weight-loss pill with $550 million inventory stockpile By Reuters - Investing.com
Eli Lilly’s (NYSE:LLY) Future Takes Aim at Big Problems in Plain Sight - TipRanks
Eli Lilly wants to use its weight loss drug windfall to fight Alzheimer's and hearing loss - Yahoo Finance
Eli Lilly obesity drug trial participants losing ‘too much weight,’ STAT reports - TipRanks
Eli Lilly aims to invest in 'big problems hiding in plain sight' using obesity windfall - CNBC
From pills to new uses, here's what Eli Lilly’s top scientist sees as the future of weight loss drugs - CNBC
Argus Adjusts Price Target on Eli Lilly to $1,000 From $980 -February 20, 2025 at 08:35 am EST - Marketscreener.com
Eli Lilly Files For Mixed Shelf Size Not DisclosedSEC Filing -February 19, 2025 at 05:46 pm EST - Marketscreener.com
Eli Lilly & Co. (LLY) Files Mixed Shelf - StreetInsider.com
Lilly, Novo Fight Weight Loss Drug Compounders Over Shortage - Bloomberg Law
ELI LILLY & Co SEC 10-K Report - TradingView
SEC Form 10-K filed by Eli Lilly and Company - Quantisnow
Fat, not muscle: drugmakers in race for next weight-loss breakthrough -February 19, 2025 at 10:06 am EST - Marketscreener.com
Digging Into What Hershey and Eli Lilly Told Investors - The Motley Fool
Merck, Lilly launch manufacturing R&D consortium to help ‘bolster’ U.S. production - PharmaVoice
Fat, not muscle: drugmakers in race for next weight-loss breakthrough -February 19, 2025 at 06:08 am EST - Marketscreener.com
Eli Lilly and Company (LLY): A Bull Case Theory - MSN
Lebanon planning board OKs design for Lilly Medicine Foundry at LEAP District - Indianapolis Business Journal
APAC deals abound: Lilly taps Advancell, Olix; Genome draws Ellipses - BioWorld Online
TD Cowen 45th Annual Health Care Conference | Eli Lilly and Company - Investors | Eli Lilly and Company
Lilly to participate in TD Cowen's 45th Annual Health Care Conference - Investors | Eli Lilly and Company
The Zacks Analyst Blog Highlights Apple, Eli Lilly, Shopify and ImmuCell - Yahoo Finance
Eli Lilly and Company (NYSE:LLY) Trading Down 3.1%Here's What Happened - MarketBeat
Chronic Lower Back Pain Market Expected to rise, 2034 | Eli Lilly - openPR
Eli Lilly & Co: Promising Growth Driven by Innovative Pipeline and Market-Leading Weight-Loss Treatments - TipRanks
TigerOak Management L.L.C. Takes $522,000 Position in Eli Lilly and Company (NYSE:LLY) - MarketBeat
Why Eli Lilly and Company (LLY) Is the Best Drug Stock to Buy Now - Insider Monkey
Eli Lilly Reports Record Q4 2024 Revenue of $13.53B, Fueled by Mounjaro, Zepbound, and Oncology Growth - BSA bureau
Lebanon planning board to review designs for Lilly’s $4.5B foundry at LEAP District - Inside INdiana Business
Think Eli Lilly's Stock Is Expensive? Here's Why Selling It Now Could Be a Huge Mistake - The Motley Fool
1,149 Shares in Eli Lilly and Company (NYSE:LLY) Acquired by CFC Planning Co LLC - MarketBeat
Eli Lilly Full-Year Earnings Meet Expectations Amid GLP-1 Inventory Challenges – market - HPBL
Major Shareholder Makes a Significant Move with Eli Lilly & Co Stock! - TipRanks
Top Stock Reports for Apple, Eli Lilly & Shopify - Yahoo Finance
Lilly Endowment sells $31.18 million in Eli Lilly stock - Investing.com
Innovating beyond boundaries: Sarah O’Keeffe’s career in making medicine - Irish Examiner
1,080 Shares in Eli Lilly and Company (NYSE:LLY) Bought by Kentucky Trust Co - MarketBeat
Eli Lilly leads M&A bond charge in US IG market - GlobalCapital
Is Eli Lilly and Company (LLY) the Best Large Cap Dividend Growth Stock to Buy Now? - Insider Monkey
Single Point Partners LLC Buys New Position in Eli Lilly and Company (NYSE:LLY) - MarketBeat
GLP-1 Drugs Drive Growth for Eli Lilly. Is the Stock a Buy? - MSN
Eli Lilly issues $6 billion in new debt securities - MSN
Eli Lilly issues $6 billion in new debt securities By Investing.com - Investing.com UK
SEC Form 8-K filed by Eli Lilly and Company - Quantisnow
Behind the Scenes of Eli Lilly's Latest Options Trends - Benzinga
AdvanCell & Lilly Expand Collaboration for Targeted Alpha Therapies - Contract Pharma
5.18%
자본화:
|
볼륨(24시간):